PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Nov-2024 TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update AccessWire
25-Nov-2024 InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates Newswire
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies Newswire
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies AccessWire
25-Nov-2024 Acreage Provides Update on Corporate Transactions AccessWire
25-Nov-2024 Moderna to Present at Upcoming Conferences in December 2024 AccessWire
25-Nov-2024 Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation AccessWire
25-Nov-2024 Coulter Partners secures industry-leading Chief Medical Officer for Solu Therapeutics Coulter Partners
25-Nov-2024 SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry SYNBIOTIC SE
25-Nov-2024 BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity AccessWire
22-Nov-2024 Comment on withdrawn non-binding offer Evotec SE
22-Nov-2024 Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE
22-Nov-2024 Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment AccessWire
22-Nov-2024 Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024 AccessWire
22-Nov-2024 Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) AccessWire
22-Nov-2024 Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs AccessWire
22-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting AccessWire
22-Nov-2024 Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm AccessWire
22-Nov-2024 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA
22-Nov-2024 Sunshine Biopharma Launches a New Generic Prescription Drug AccessWire